In 2017, the Competent Cells market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In United States market, the top players include
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems

Split by product types/category, covering
Chemically Competent Cells
Electrocompetent Cells

Split by applications/end use industries, covers
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)